2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]-

2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]- Suppliers list
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Shanghai Amole Biotechnology Co., Ltd.  
Tel: 13370042665 18916960931
Email: 2596183085@qq.com
2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]- Basic information
Product Name:2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]-
Synonyms:2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]-;GRK6-IN-2
CAS:2677786-27-3
MF:C21H21FN6
MW:376.43
EINECS:
Product Categories:
Mol File:2677786-27-3.mol
2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]- Structure
2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]- Chemical Properties
Boiling point 612.5±65.0 °C(Predicted)
density 1.334±0.06 g/cm3(Predicted)
pka14.27±0.10(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]- Usage And Synthesis
UsesGRK6-IN-2 (compound 10a) is a potent inhibitor of G protein-coupled receptor kinase 6 (GRK6) with an IC50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-2 has the potential for the research of multiple myeloma[1].
References[1] Uehling DE, et al. Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma [published correction appears in J Med Chem. 2022 Jan 13;65(1):886-887]. J Med Chem. 2021;64(15):11129-11147. DOI:10.1021/acs.jmedchem.1c00506
2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]- Preparation Products And Raw materials
Tag:2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]-(2677786-27-3) Related Product Information
Ethyl 8-methoxy-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-4-carboxylate AT9283 PF 477736 Anti-Aging Compound Library 2,4-Quinazolinediamine, N2-[(4-chloro-2-methoxyphenyl)methyl]-N4-(5-ethyl-1H-pyrazol-3-yl)-5-methoxy- Anti-cancer compound library